Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
Campus
Campus

Time-In-Range (TIR): How to interpret it and how it is associated with outcomes

Watch the Interview with Dr. Richard Bergenstal, International Diabetes Center, Minneapolis, USA following the ATTD 2021 Congress. Dr. Richard Bergenstal explains on how to interpret TIR and how it is associated with outcomes.

Related articles
Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

Read article
Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Read article
Challenges associated with commonly-used insulin advancement options

Challenges associated with commonly-used insulin advancement options

Read article
MAT-BH-2300621/v1/November 2023